Objective In early 2010, Harvard Medical School and Boston Children’s Hospital began an
interoperability project with the distinctive goal of developing a platform to enable medical …

Drug repurposing provides a rapid approach to meet the urgent need for therapeutics to
address COVID-19. To identify therapeutic targets relevant to COVID-19, we conducted …

Large-scale multi-ethnic cohorts offer unprecedented opportunities to elucidate the genetic
factors influencing complex traits related to health and disease among minority populations. …

One major challenge encountered with interpreting human genetic variants is the limited
understanding of the functional impact of genetic alterations on biological processes. …

Diagnosis at the edges of our knowledge calls upon clinicians to be data driven, cross-disciplinary,
and collaborative in unprecedented ways. Exact disease recognition, an element of …

Objective The Substitutable Medical Applications, Reusable Technologies (SMART)
Platforms project seeks to develop a health information technology platform with substitutable …

Introduction The inability of some seriously and chronically ill individuals to receive a definitive
diagnosis represents an unmet medical need. In 2008, the NIH Undiagnosed Diseases …

Background Available COVID-19 mortality indices are limited to acute inpatient data. Using
nationwide medical administrative data available prior to SARS-CoV-2 infection from the US …

Drawing from real-life scenarios and insights shared at the RAISE (Responsible AI for Social
and Ethical Healthcare) conference, we highlight the critical need for AI in health care (AIH) …

The value of large-scale, real-world data—from electronic health records (EHRs), for
example—has been used to establish vaccine efficacy, to elucidate the genetic etiologies of …